- Home
- WBS vs SNN Comparison
WBS vs SNN Comparison
Compare WBS & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WBS
- SNN
- Stock Information
- Founded
- WBS 1935
- SNN 1856
- Country
- WBS United States
- SNN United Kingdom
- Employees
- WBS N/A
- SNN N/A
- Industry
- WBS Major Banks
- SNN Industrial Specialties
- Sector
- WBS Finance
- SNN Health Care
- Exchange
- WBS Nasdaq
- SNN Nasdaq
- Market Cap
- WBS 10.2B
- SNN 10.8B
- IPO Year
- WBS N/A
- SNN 1999
- Fundamental
- Price
- WBS $61.76
- SNN $25.32
- Analyst Decision
- WBS Buy
- SNN Strong Buy
- Analyst Count
- WBS 13
- SNN 1
- Target Price
- WBS $57.54
- SNN N/A
- AVG Volume (30 Days)
- WBS 1.4M
- SNN 1.1M
- Earning Date
- WBS 01-21-2025
- SNN 08-01-2024
- Dividend Yield
- WBS 2.59%
- SNN 2.96%
- EPS Growth
- WBS N/A
- SNN 39.77
- EPS
- WBS 4.42
- SNN 0.35
- Revenue
- WBS $2,368,947,000.00
- SNN $5,642,000,000.00
- Revenue This Year
- WBS N/A
- SNN $6.97
- Revenue Next Year
- WBS $6.34
- SNN $5.46
- P/E Ratio
- WBS $13.98
- SNN $35.30
- Revenue Growth
- WBS N/A
- SNN 5.48
- 52 Week Low
- WBS $39.34
- SNN $23.65
- 52 Week High
- WBS $61.86
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- WBS 71.16
- SNN 39.79
- Support Level
- WBS $58.55
- SNN $24.93
- Resistance Level
- WBS $60.96
- SNN $25.57
- Average True Range (ATR)
- WBS 1.64
- SNN 0.37
- MACD
- WBS 0.09
- SNN 0.18
- Stochastic Oscillator
- WBS 99.18
- SNN 75.38
About WBS Webster Financial Corporation
Webster Financial Corp is a full-service provider of financial services, offering commercial and consumer banking, mortgages, and investment advisory along with trust and wealth management services in Connecticut, New York, Rhode Island, Massachusetts, and Pennsylvania. The company's segment includes Commercial Banking, HSA Bank, and Consumer Banking. It generates maximum revenue from the Commercial Banking segment.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.